ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 802,07
1,47%
DAX
18 518,03
-0,44%
Brent Oil
83,535
-0,95%
Bitcoin
64 543,12
-0,48%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
30/04/201517h47Business WireTeva invia lettera al CdA di MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201517h15The Motley FoolTeva Pharmaceutical Industries Ltd. Posts Strong First-Quarter Earnings: Is the Stock Now a Buy?NYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201515h37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201514h48Business Wireテバ、現金と株式交換による1株当たり82.00ドルでのマイラン買収を提案NYSE:TEVATeva Pharmaceutical Industries Ltd
30/04/201514h30Dow Jones NewsTeva Raises Guidance as Generic-Medicine Segment GrowsNYSE:TEVATeva Pharmaceutical Industries Ltd.
30/04/201513h00Business WireTeva Reports First Quarter 2015 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/201522h13Business WireTeva Sends Letter to Mylan BoardNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/201517h43Dow Jones NewsMylan Boosts Offer for Perrigo to $35.6 Billion -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
29/04/201516h20Dow Jones NewsMylan Boosts Offer for Perrigo to $35.6 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/201516h17Dow Jones NewsMylan Boosts Offer for Perrigo to $35.6 Billion--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
29/04/201513h21Analyst Ratings NetworkTeva Pharmaceutical Industries Upgraded at Standpoint Research (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201521h21Business WireTeva Launches Generic Abilify® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201518h21Business WireTeva bekräftigt sein Engagement für die Übernahme von Mylan für 82,00 US-Dollar je Aktie in bar und in Form von Aktien de...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201514h30Business WireTeva Continues to Invigorate Injectable Portfolio with the Launch of Argatroban Injection in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201510h46Business WireTeva ripete l'impegno nei confronti dell'acquisizione di Mylan in contanti e titoli a $82,00 per azioneNYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201505h35Business WireTeva réitère son engagement au regard de l'acquisition en numéraire et en actions de Mylan au prix de 82,00 dollars US par...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201504h05Dow Jones NewsMylan Rejects Teva's Unsolicited $40 Billion Bid--4th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/201500h31Dow Jones NewsADR Shares End Mixed; Teva DeclinesNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/201523h10Dow Jones NewsU.S. Stocks End LowerNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/201521h26Dow Jones NewsMylan Rejects Teva's Unsolicited $40 Billion Bid--3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
27/04/201519h41Dow Jones NewsMylan Rejects Teva's Unsolicited $40 Billion Bid--2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
27/04/201517h34Dow Jones NewsMylan Rejects Teva's Unsolicited $40 Billion BidNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/201516h37Business WireTeva Reiterates Commitment to Cash-and-Stock Acquisition of Mylan for $82.00 Per ShareNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/201515h19PR Newswire (US)Mylan Board Unanimously Rejects Unsolicited Expression of Interest from TevaNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/201512h30PR Newswire (Canada)OncoGenex Regains Rights to Custirsen from TevaNYSE:TEVATeva Pharmaceutical Industries Ltd
26/04/201517h04The Motley FoolBig Pharma Comes Under Attack From a New Hedge Fund StrategyNYSE:TEVATeva Pharmaceutical Industries Ltd
25/04/201513h06The Motley FoolAre Biosimilars the Next Big Thing in Biotech?NYSE:TEVATeva Pharmaceutical Industries Ltd
24/04/201523h18Analyst Ratings NetworkTeva Pharmaceutical Industries's Buy Rating Reaffirmed at Gabelli (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
24/04/201521h59Dow Jones NewsMylan Raises Bid for Generic Drug Maker Perrigo -- 6th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
24/04/201519h04Dow Jones NewsMylan Raises Bid for Generic Drug Maker Perrigo -- 5th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NYSE
MCD
McDonalds
EU
BNP
BNP Paribas
EU
PX1
CAC 40
EU
AI
Air Liquide
NASDAQ
AAPL
Apple
EU
GLE
Societe Generale
NYSE
MRK
Merck
EU
DG
Vinci
EU
ACA
Credit Agricole
EU
RNO
Renault
EU
VK
Vallourec
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés